Part 14.
TEXAS OPTOMETRY BOARD
Chapter 279.
INTERPRETATIONS
22 TAC §279.1
The Texas Optometry Board adopts amendments to §279.1
with the following change to the proposed text published in the December 22,
2000, issue of the
Texas Register
(25 TexReg
12589): Section "351.359" is added to the list of authority in subsection
(a).
The amendments update the items a contact lens prescription must contain,
including the deletion of some items no longer necessary to write a complete
prescription, the addition of restrictions contained in the Contact Lens Prescription
Act regarding length of prescription, and the addition of explanatory language
concerning substitution of brand names for private labels versus prescribing
of proprietary lenses.
The Board (agency) received comments from the Texas Department of Health,
Contact Lens Dispensing Permit Program (the Department). The Department commented
that it is against adoption of the amendments. No other comments on the rule
were received.
The Department commented that language should be added to subsection (b)(3)
directing the doctor to verbally explain to the patient and document in the
patient's record the reasons that the prescription was for a period of less
than one year. The Agency disagrees with the commentor that this statement
is appropriate in a rule that defines the contents of a prescription and not
the legal requirements for providing a prescription.
The Department commented that §279.12 had been in effect for several
years and that the Agency was changing the rule, and in its comments posed
several questions regarding when a proprietary lens was medically indicated.
The Agency disagrees with these comments. Section 351.359 of the Texas Optometry
Act prohibits a prescription from containing a restriction that limits the
parameters to a private label not available to the industry as a whole. The
amended language of the rule, as did the original rule language of §279.12
concerning private labels, similarly prohibits such a restriction in a prescription
by requiring the inclusion of substitution language. A proprietary lens, which
unlike a private label lens is not intended to be an exclusive lens solely
because of a brand name, may be medically indicated, for example, in the advanced
geometric designs for treating keratoconus or corneal anomalies. Section 351.359
does not prohibit the prescribing of a proprietary lens when medically indicated.
The Department commented that a certain type of lens was a proprietary
lens and since it was not available to the public as a whole, could not be
prescribed by an optometrist. The Agency disagrees with this comment. The
lens referred to by the Department, if not available to the industry as a
whole, would properly be classified as a private label and not a proprietary
lens. However, the referenced lens is available to the optical industry as
a whole. If the lens were a private label, the rule would require substitution
language in the prescription.
The Department commented that the Contact Lens Prescription Act prohibits
conditioning the issuance of a prescription on the condition that contact
lenses be purchased from the prescribing doctor. The commentor stated that
the amendments to the rule regarding proprietary lenses would permit the doctor
to restrict the prescription to a proprietary lens that is interchangeable
with a non-proprietary lens without a benefit to the ocular health of the
patient. The Agency disagrees with these comments. The rule amendments are
made pursuant to §351.359 of the Optometry Act. A proprietary lens is
not a private label lens but a lens that offers clinical superiority for specific
medical conditions, and may only be prescribed when medically indicated. Although
a proprietary lens may not be offered by every contact lens dispenser, the
lenses are commonly available to a large segment of dispensers and not restricted
by brand name to one doctor or practice. Therefore the prescribing of such
a lens will not require the patient to obtain the lenses from the prescribing
doctor.
The Department commented that if a proprietary lens were prescribed, the
rule should require that the prescribing doctor verbally inform the patient
and document in the record the reasons for prescribing the proprietary lens.
The Agency disagrees that there is any legal authority or requirement for
such a provision.
The amended rule is adopted under the Texas Optometry Act, Texas
Occupations Code, §§351.151, 351.356, 351.357, 351.359, and 351.607,
and Contact Lens Prescription Act, §§353.152, 353.153, and 353.158.
The Texas Optometry Board interprets §351.151 as authorizing the adoption
of procedural and substantive rules for the regulation of the optometric profession.
The Board interprets §§351.151, 351.356, 351.357, 351.359, 351.607,
353.152, 353.153, and 353.158, as defining the requirements for a contact
lens prescription.
§279.1.Board Interpretation Number One
(a)
A contact lens prescription must comply with the requirements
of the Texas Optometry Act, §§351.005, 351.356, 351.357, 351.359
and 351.607, and the Contact Lens Prescription Act, §§353.152, 353.153
and 353.158.
(b)
A fully written contact lens prescription must contain
all information required to accurately dispense the contact lens, including:
(1)
patient's name;
(2)
date the prescription is issued;
(3)
expiration date of the prescription, which shall be one
year or more unless a shorter period is medically indicated;
(4)
examining optometrist's signature or authorized signature
in compliance with Rule §279.14(b);
(5)
name of the lens manufacturer, if required to accurately
dispense the lens;
(6)
lens brand name, including:
(A)
a statement that brand substitution is permitted if the
optometrist intends to authorize a contact lens dispenser to substitute the
brand name, and
(B)
a statement specifying a substitute brand name when the
prescribed brand name is not available to the optical industry as a whole,
unless the prescribing of a proprietary lens brand is medically indicated;
(7)
lens power;
(8)
lens diameter, unless set by the manufacturer;
(9)
base curve, unless set by the manufacturer; and
(10)
number of lenses and recommended replacement interval.
This agency hereby certifies that the adoption has been
reviewed by legal counsel and found to be a valid exercise of the agency's
legal authority.
Filed with the Office of
the Secretary of State on March 15, 2001.
TRD-200101538
Lois Ewald
Executive Director
Texas Optometry Board
Effective date: April 4, 2001
Proposal publication date: December 22, 2000
For further information, please call: (512) 305-8500
22 TAC §279.12
The Texas Optometry Board adopts amendments to §279.12
without changes to the proposed text published in the December 22, 2000, issue
of the
Texas Register
(25 TexReg 12590).
The amendments clarify the limited situations in which a proprietary lens
may be prescribed.
The Board (agency) received comments from the Texas Department of Health,
Contact Lens Dispensing Permit Program (the Department). The Department commented
that it is against adoption of the amendments. No other comments on the rule
were received.
The Department commented that §279.12 had been in effect for several
years and that the Agency was changing the rule, and in its comments posed
several questions regarding when a proprietary lens was medically indicated.
The Agency disagrees with these comments. Section 351.359 of the Texas Optometry
Act prohibits a prescription from containing a restriction that limits the
parameters to a private label not available to the industry as a whole. The
amended language of the rule, as did the original rule language of §279.12
concerning private labels, similarly prohibits such a restriction in a prescription
by requiring the inclusion of substitution language. A proprietary lens, which
unlike a private label lens is not intended to be an exclusive lens solely
because of a brand name, may be medically indicated, for example, in the advanced
geometric designs for treating keratoconus or corneal anomalies. Section 351.359
does not prohibit the prescribing of a proprietary lens when medically indicated.
The Department commented that a certain type of lens was a proprietary
lens and since it was not available to the public as a whole, could not be
prescribed by an optometrist. The Agency disagrees with this comment. The
lens referred to by the Department, if not available to the industry as a
whole, would properly be classified as a private label and not a proprietary
lens. However, this lens is available to the optical industry as a whole.
If the lens were a private label, the rule would require substitution language
in the prescription.
The Department commented that the Contact Lens Prescription Act prohibits
conditioning the issuance of a prescription on the condition that contact
lenses be purchased from the prescribing doctor. The commentor stated that
the amendments to the rule regarding proprietary lenses would permit the doctor
to restrict the prescription to a proprietary lens that is interchangeable
with a non-proprietary lens without a benefit to the ocular health of the
patient. The Agency disagrees with these comments. The rule amendments are
made pursuant to Section 351.359 of the Optometry Act. A proprietary lens
is not a private label lens but a lens that offers clinical superiority for
specific medical conditions, and may only be prescribed when medically indicated.
Although a proprietary lens may not be offered by every contact lens dispenser,
the lenses are commonly available to a large segment of dispensers and not
restricted by brand name to one doctor or practice. Therefore the prescribing
of such a lens will not require the patient to obtain the lenses from the
prescribing doctor.
The Department commented that if a proprietary lens were prescribed, the
rule should require that the prescribing doctor verbally inform the patient
and document in the record the reasons for prescribing the proprietary lens.
The Agency disagrees that there is any legal authority or requirement for
such a provision.
The amended rule is adopted under the Texas Optometry Act, Texas
Occupations Code, §§351.151 and 351.359. The Texas Optometry Board
interprets §351.151 as authorizing the adoption of procedural and substantive
rules for the regulation of the optometric profession. The Board interprets §351.359
as defining the requirements for a contact lens prescription.
This agency hereby certifies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency's legal authority.
Filed with the Office of
the Secretary of State on March 15, 2001.
TRD-200101539
Lois Ewald
Executive Director
Teas Optometry Board
Effective date: April 4, 2001
Proposal publication date: December 22, 2000
For further information, please call: (512) 305-8500
Chapter 597.
UNLAWFUL ACTS AND GROUNDS FOR REVOCATION
22 TAC §597.2
The Structural Pest Control Board adopts amendments of 22
TAC 597.2 without changes to the proposed text published in the January 5,
2001 issue of the
Texas Register
(26 TexReg
57).
The justification for the rule will allow expedited review by suspension
or revocation of licenses the Board has determined no longer able to obey
the Board's laws and regulations.
The rule will function in that the licensee must request a hearing within
20 days of the date of the letter setting out legal basis and supporting facts
challenging Board decision and relief sought by petitioner.
There were no comments received.
There were no groups or associations making comments for or against the
rule.
The amendment is adopted under Tex.Rev.Civ.Stat.Ann., Article
135b-6, which provides the Structural Pest Control Board with the authority
to license and regulate the structural pest control industry.
This agency hereby certifies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency's legal authority.
Filed with the Office of
the Secretary of State on March 16, 2001.
TRD-200101554
Benny M. Mathis, Jr.
Executive Director
Structural Pest Control Board
Effective date: April 5, 2001
Proposal publication date: January 5, 2001
For further information, please call: (512) 451-7200
Part 25.
STRUCTURAL PEST CONTROL BOARD
Chapter 599.
TREATMENT STANDARDS